Pharmanex Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Pharmanex Inc.
CBD Format – Spectrum Or Isolate? – Likely To Be Differentiator Tried In FDA Forum, Courts
Companies choosing between CBD options – namely broad- or full-spectrum hemp extracts or CBD isolate – need to appreciate the differences and potential legal implications, attorneys say.
Red Yeast Rice History Offers Blueprint For Clearing CBD As Dietary Ingredient
Legal dispute between FDA and Pharmanex decided in 1999 could be precedent for using hemp-derived ingredients including CBD in supplements, even though CBD already has been authorized for clinical drug evaluation and for use in a drug, says attorney Miriam Guggenheim.
People in Brief
Baruch jumps to Schiff from Coca-Cola for chief commercial officer role; Perrigo adds Larson for supply chain security; Revo Biolabs’ Balbert retires again; researcher Bushnell leads NCCAM’s new pain program; USANA hires Smidt as R&D VP; Vega ambassadors head to Olympics.
People in Brief
Baruch jumps to Schiff from Coca-Cola for chief commercial officer role; Perrigo adds Larson for supply chain security; Revo Biolabs’ Balbert retires again; researcher Bushnell leads NCCAM’s new pain program; USANA hires Smidt as R&D VP; Vega ambassadors head to Olympics.
Company Information
- Industry
-
Pharmaceuticals
- OTC, Consumer
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice